UNSPSC 51112301: Busulfan

This classification denotes an alkylsulfonate compound with the molecular formula C6H14O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G1LN9045DK, chemically known as 1,4-dimethylsulfonyloxybutane but more generally known as busulfan, which bears US NIH Compound Identifier 2478. Busulfan most often comes in base and mannitol forms. European Medicines Agency schedules Busulfan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05993MIG.

UNSPSC 51112301 Busulfan is a Commodity code naming a single pharmaceutical product—an alkylating agent chemotherapy drug used primarily in hematologic malignancy treatment and bone marrow transplant conditioning regimens. State and local governments procure busulfan through their health and human services departments, Medicaid agencies, public hospital systems, and correctional health programs as part of formulary procurement and specialized cancer care sourcing. The drug appears in both routine pharmacy contract competitions and in disease-specific therapeutic protocols managed by state oncology networks and public academic medical centers.

The source provides no recent state or local contract opportunities tagged to UNSPSC 51112301 Busulfan. Without posted RFPs, RFQs, IBs, or ITBs in the opportunities block, no geographic concentration, issuing-body mix, or representative solicitations can be characterized from current market activity.